open access

Vol 58, No 5 (2007)
Original papers
Published online: 2007-10-16
Submitted: 2013-02-15
Get Citation

The estimation of the goiter by means of ultrasonography and scintigraphy (SPECT) with using 131I

Marcin Gierach, Joanna Gierach, Stanisław Pilecki, Roman Junik
Endokrynologia Polska 2007;58(5):403-407.

open access

Vol 58, No 5 (2007)
Original papers
Published online: 2007-10-16
Submitted: 2013-02-15

Abstract

Introduction: Ultrasonography (US) and scintigraphy (SPECT) are used to evaluate the volume of thyroid glands. An accurate estimation of the thyroid volume, among other factors, is necessary to calculate the suitable radioactive iodine dose, which determines the success of the therapy. The aim of the study was to estimate the volume of the goiter by means of US and 131I-SPECT.
Material and methods: A group of 80 patients with a thyroid disorder in their past medical history was examined. Patients were divided into two groups. The group A contained 50 patients (39 females, 11 males) with a goiter, where the volume of the thyroid was evaluated with the use of US and 131I-SPECT. The group B contained 30 patients (21 females, 9 males) with a normal volume of the thyroid gland shown by US and 131I-SPECT. US of the thyroid gland was made by means of an ALOKA SSD 500 device, with the linear head 7.5 MHz frequency. 131I-SPECT was made by means of a one head gammacamera Diacam with a high energy collimator.
Results: In the group A, the average volume of the goiter was 44.55 ml in US and 49.67 ml in SPECT (p < 0.001). In control group B the average volumes of the thyroid gland were respectively 13.83 ml vs. 16.19 ml (p < 0.001).
Conclusion: The results of the thyroid volume measurement was dependant on the method used in both the investigated and control groups.
(Pol J Endocrinol 2007; 58 (5): 403-407)

Abstract

Introduction: Ultrasonography (US) and scintigraphy (SPECT) are used to evaluate the volume of thyroid glands. An accurate estimation of the thyroid volume, among other factors, is necessary to calculate the suitable radioactive iodine dose, which determines the success of the therapy. The aim of the study was to estimate the volume of the goiter by means of US and 131I-SPECT.
Material and methods: A group of 80 patients with a thyroid disorder in their past medical history was examined. Patients were divided into two groups. The group A contained 50 patients (39 females, 11 males) with a goiter, where the volume of the thyroid was evaluated with the use of US and 131I-SPECT. The group B contained 30 patients (21 females, 9 males) with a normal volume of the thyroid gland shown by US and 131I-SPECT. US of the thyroid gland was made by means of an ALOKA SSD 500 device, with the linear head 7.5 MHz frequency. 131I-SPECT was made by means of a one head gammacamera Diacam with a high energy collimator.
Results: In the group A, the average volume of the goiter was 44.55 ml in US and 49.67 ml in SPECT (p < 0.001). In control group B the average volumes of the thyroid gland were respectively 13.83 ml vs. 16.19 ml (p < 0.001).
Conclusion: The results of the thyroid volume measurement was dependant on the method used in both the investigated and control groups.
(Pol J Endocrinol 2007; 58 (5): 403-407)
Get Citation

Keywords

goiter; thyroid US; thyroid SPECT; radioiodine

About this article
Title

The estimation of the goiter by means of ultrasonography and scintigraphy (SPECT) with using 131I

Journal

Endokrynologia Polska

Issue

Vol 58, No 5 (2007)

Pages

403-407

Published online

2007-10-16

Bibliographic record

Endokrynologia Polska 2007;58(5):403-407.

Keywords

goiter
thyroid US
thyroid SPECT
radioiodine

Authors

Marcin Gierach
Joanna Gierach
Stanisław Pilecki
Roman Junik

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl